Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate

Ward, Patrick S., Thompson, Craig B.·2012·Cancer Cell

Cited by (1,011)

Items 201–300 of 1,011

  1. Metabolic Imaging of the Human Brain with Hyperpolarized 13C Pyruvate Demonstrates 13C Lactate Production in Brain Tumor Patients
    Vesselin Z. Miloushev, Kristin L. Granlund, Rostislav Boltyanskiy, Serge K. Lyashchenko, Lisa Marie DeAngelis, Ingo K. Mellinghoff, Cameron Walter Brennan, Vivian Tabar, Jonathan T. Yang, Andrei I. Holodny et al. · 2018 · Cancer Research
  2. The Mitochondrion as an Emerging Therapeutic Target in Cancer
    Katherine G. Roth, Isa Mambetsariev, Prakash Kulkarni, Ravi Salgia · 2019 · Trends in Molecular Medicine
  3. Pluripotent stem cell energy metabolism: an update
    Tara A. TeSlaa, Michael A. Teitell · 2014 · The EMBO Journal
  4. Molecular intricacies of aerobic glycolysis in cancer: Current insights into the classic metabolic phenotype
    Ganapathy-Kanniappan, Shanmugasundaram · 2018 · Critical Reviews in Biochemistry and Molecular Biology
  5. Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics
    Manti Guha, Narayan G. Avadhani · 2013 · Mitochondrion
  6. Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy
    Marco Tomasetti, Wan Lee, Lory Santarelli, Jiřı́ Neužil · 2017 · Experimental & Molecular Medicine
  7. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
    Liangliang Shen, John M. O’Shea, Mohan Rao Kaadige, Stéphanie Cunha, Blake R. Wilde, Adam Louis Cohen, Alana L. Welm, Donald E. Ayer · 2015 · Proceedings of the National Academy of Sciences
  8. Targeting OXPHOS and the electron transport chain in cancer; Molecular and therapeutic implications
    John Patrick Greene, Ashvina Segaran, Simon Lord · 2022 · Seminars in Cancer Biology
  9. Dichloroacetate and cancer: New home for an orphan drug?
    Shyam Kankotia, Peter W. Stacpoole · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  10. NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance
    Tingjin Chen, Zhigang Xu, Jie Luo, Rajesh Manne, Zhengyu Wang, Che-Chia Hsu, Bo‐Syong Pan, Zhen Cai, Pei‐Jane Tsai, Yau-Sheng Tsai et al. · 2023 · Cell Metabolism
  11. Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia
    Shiro Koizume, Yohei Miyagi · 2016 · International Journal of Molecular Sciences
  12. Purine synthesis promotes maintenance of brain tumor initiating cells in glioma
    Xiuxing Wang, Kailin Yang, Qi Xie, Qiulian Wu, Stephen C. Mack, Yu Shi, Leo J.Y. Kim, Briana C. Prager, William A. Flavahan, Xiaojing Liu et al. · 2017 · Nature Neuroscience
  13. Mitochondrial ROS and cancer drug resistance: Implications for therapy
    Okon, Imoh S., Zou, Ming-Hui · 2015 · Pharmacological Research
  14. Low abundance of the matrix arm of complex I in mitochondria predicts longevity in mice
    Satomi Miwa, Howsun Jow, Karen Baty, Amy Jo Johnson, Rafal Czapiewski, Gabriele Christine Saretzki, Achim Treumann, Thomas von Zglinicki · 2014 · Nature Communications
  15. Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium( iii ) complexes
    Jianjun Cao, Cai‐Ping Tan, Mu‐He Chen, Na Wu, Deyang Yao, Xingguo Liu, Liang‐Nian Ji, Zong‐Wan Mao · 2016 · Chemical Science
  16. Deciphering p53 signaling in tumor suppression
    Stephano S. Mello, Laura Donatella Attardi · 2017 · Current Opinion in Cell Biology
  17. Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch
    Jayantha B. Tennakoon, Yan Shi, Jing Han, Efrosini Tsouko, M A White, Alan R. Burns, Anli Zhang, Xuefeng Xia, Olga Ilkayeva, Li Xin et al. · 2013 · Oncogene
  18. Roles of microRNA on cancer cell metabolism
    Bing Chen, Hongbin Li, Xiaoyun Zeng, Pengbo Yang, Xinyu Liu, Xia Zhao, Shufang Liang · 2012 · Journal of Translational Medicine
  19. Metabolic reprogramming in renal cancer: Events of a metabolic disease
    Samik Chakraborty, Murugabaskar Balan, Akash Sabarwal, Toni K. Choueiri, Soumitro Pal · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  20. Isocitrate Dehydrogenase Mutation and ( <i>R</i> )-2-Hydroxyglutarate: From Basic Discovery to Therapeutics Development
    Dang, Lenny, Su, Shin-San Michael · 2017 · Annual Review of Biochemistry
  21. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans
    Li Che, Wenna Chi, Yu Qiao, Jie Zhang, Xinhua Song, Ye Liu, Lei Li, Jiaoyuan Jia, Maria G. Pilo, Jingxiao Wang et al. · 2019 · Gut
  22. Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
    Y-C Shen, Da‐Liang Ou, Chiun Hsu, K-L Lin, C-Y Chang, C-Y Lin, Shing‐Hwa Liu, A-L Cheng · 2012 · British Journal of Cancer
  23. Single-Cell Profiles and Clinically Useful Properties of Human Mesenchymal Stem Cells of Adipose and Bone Marrow Origin
    Wenyan Zhou, Junxin Lin, Kun Zhao, Kaixiu Jin, Qiulin He, Yejun Hu, Gang Feng, Youzhi Cai, Chen Xia, Hua Liu et al. · 2019 · The American Journal of Sports Medicine
  24. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
    Tongxin Ge, Xiang Gu, Renbing Jia, Shengfang Ge, Peiwei Chai, Ai Zhuang, Xianqun Fan · 2022 · 癌症:英文版
  25. Lipid metabolism emerges as a promising target for malignant glioma therapy
    Deliang Guo, Erica Hlavin Bell, Arnab Chakravarti · 2013 · CNS Oncology
  26. How does cancer cell metabolism affect tumor migration and invasion?
    Tianyu Han, De Kang, Daokun Ji, Xiaoyu Wang, Weihua Zhan, Minggui Fu, Hong-Bo Xin, Jian-Bin Wang · 2013 · Cell Adhesion & Migration
  27. When less may be more: calorie restriction and response to cancer therapy
    Ciara H. O’Flanagan, Laura A. Smith, Shannon B. McDonell, Stephen David Hursting · 2017 · BMC Medicine
  28. The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues
    Goetzman, Eric S., Prochownik, Edward V. · 2018 · Frontiers in Endocrinology
  29. Adaptive Reprogramming of <i>De Novo</i> Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer
    Brown, Kristin K., Spinelli, Jessica B., Asara, John M., Toker, Alex · 2017 · Cancer Discovery
  30. Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy
    Soumaya Kouidhi, Farhat Ben Ayed, Amel Benammar Elgaaïed · 2018 · Frontiers in Immunology
  31. Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
    Alberto Cruz‐Bermúdez, Raquel Laza Briviesca, Ramiro J. Vicente-Blanco, Aránzazu García‐Grande, María José Coronado, Sara Laine-Menéndez, Sara Palacios-Zambrano, M. Rocío Moreno-Villa, Asunción Martín Ruiz-Valdepeñas, Cristina Lendinez et al. · 2019 · Free Radical Biology and Medicine
  32. PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion
    M. Cecilia Caino, Jagadish C. Ghosh, Young Chan Chae, Valentina Vaira, Dayana B. Rivadeneira, Alice Faversani, Paolo Maria Rampini, Andrew V. Kossenkov, Katherine M. Aird, Rugang Zhang et al. · 2015 · Proceedings of the National Academy of Sciences
  33. Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1
    Hairui Wang, Yisi Tang, Yuefei Fang, Meng Zhang, Huiyuan Wang, Zhidi He, Bing Wang, Qin Xu, Yongzhuo Huang · 2019 · Nano Letters
  34. Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells
    Xiuxing Wang, Kailin Yang, Qiulian Wu, Leo J.Y. Kim, Andrew R. Morton, Ryan C. Gimple, Briana C. Prager, Yu Shi, Wenchao Zhou, Shruti Bhargava et al. · 2019 · Science Translational Medicine
  35. From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?
    vel Szic, Katarzyna Szarc, Declerck, Ken, Vidaković, Melita, Vanden Berghe, Wim · 2015 · Clinical Epigenetics
  36. The Warburg Effect Revisited—Lesson from the Sertoli Cell
    Pedro Fontes Oliveira, Ana Dias Martins, Ana C. Moreira, C. Yan Cheng, Marco Gouveia Alves · 2014 · Medicinal Research Reviews
  37. Targeting Bacterial Central Metabolism for Drug Development
    Paul Murima, John D. McKinney, Kévin Pethe · 2014 · Chemistry & Biology
  38. Unique Metabolic Adaptations Dictate Distal Organ-Specific Metastatic Colonization
    Tanya Schild, Vivien Low, John Blenis, Ana P. Gomes · 2018 · Cancer Cell
  39. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer
    Mei Yi, Yuanyuan Ban, Yixin Tan, Wei Xiong, Guiyuan Li, Bo Xiang · 2018 · Molecular Metabolism
  40. Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene
    Arnaldur Hall, Kathrine Damm Meyle, Marina Krarup Lange, Martin Klima, May Sanderhoff, Christina Dahl, Cecilie Abildgaard, Katrine Thorup, Seyed Moein Moghimi, Per Bo Jensen et al. · 2013 · Oncotarget
  41. The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications
    Zheqiong Tan, Xiangjian Luo, Lanbo Xiao, Min Tang, Ann M. Bode, Zigang Dong, Ya Cao · 2016 · Molecular Cancer Therapeutics
  42. Sirtuins in metabolism, DNA repair and cancer
    Zhen Mei, Xian Zhang, Jiarong Yi, Junjie Huang, Jian He, Yongguang Tao · 2016 · Journal of Experimental & Clinical Cancer Research
  43. Mitochondrial Stress Response and Cancer
    Jordan O’Malley, Rahul Kumar, Joseph R. Inigo, Nagendra Yadava, Dhyan Chandra · 2020 · Trends in cancer
  44. Gain of Glucose-Independent Growth upon Metastasis of Breast Cancer Cells to the Brain
    Jinyu Chen, Ho-Jeong Lee, Xuefeng Wu, Lei Huo, Sun-Jin Kim, Lei Xu, Yan Wang, Junqing He, Lakshmi Reddy Bollu, Guang Gao et al. · 2014 · Cancer Research
  45. Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
    Azhar Ali, Elena Levantini, Jun Ting Teo, Julian Goggi, John G. Clohessy, Chan Wu, Leilei Chen, Henry He Yang, Indira Krishnan, Olivier N. Kocher et al. · 2018 · EMBO Molecular Medicine
  46. Expanding perspectives on the significance of mitophagy in cancer
    Lauren E. Drake, Maya Z. Springer, Logan P. Poole, Casey Kim, Kay F. Macleod · 2017 · Seminars in Cancer Biology
  47. Direct Visualization of De novo Lipogenesis in Single Living Cells
    Junjie Li, Ji‐Xin Cheng · 2014 · Scientific Reports
  48. Roles of Aldolase Family Genes in Human Cancers and Diseases
    Yu‐Chan Chang, Yi‐Chieh Yang, Chia‐Ping Tien, Chih‐Jen Yang, Michael Hsiao · 2018 · Trends in Endocrinology and Metabolism
  49. Modeling cancer metabolism on a genome scale
    Keren Yizhak, Barbara Chaneton, Eyal Gottlieb, Eytan Ruppin · 2015 · Molecular Systems Biology
  50. Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
    Franziska Baenke, Barbara Chaneton, Matthew Smith, Niels J. F. van den Broek, Kate Hogan, Haoran Tang, Amaya Virós, Matthew J. Martin, Laura C.A. Galbraith, María Romina Girotti et al. · 2015 · Molecular Oncology
  51. Regulation and function of pyruvate kinase M2 in cancer
    Weiwei Yang, Zhimin Lu · 2013 · Cancer Letters
  52. The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation
    Remco Jurriaan Molenaar, Tomas Radivoyevitch, Jaroslaw Pawel Maciejewski, Cornelis J.F. Van Noorden, Fonnet E. Bleeker · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  53. Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2
    Roxana Simona Redis, Luz E. Vela, Weiqin Lu, Juliana Ferreira de Oliveira, Cristina Ivan, Cristian Rodriguez‐Aguayo, Douglas Adamóski, Barbara Pasculli, Ayumu Taguchi, Yunyun Chen et al. · 2016 · Molecular Cell
  54. Mitochondrial Fission in Human Diseases
    Madhavika N. Serasinghe, Jerry E. Chipuk · 2016 · Handbook of experimental pharmacology
  55. Bortezomib resistance in multiple myeloma is associated with increased serine synthesis
    Esther A. Zaal, Wei Wu, Gerrit Jansen, Sonja Zweegman, Jacqueline J Cloos, Celia R. Berkers · 2017 · Cancer & Metabolism
  56. Mitochondrial oxidative stress is the achille's heel of melanoma cells resistant to Braf-mutant inhibitor
    Paola Corazao-Rozas, Pierre Guerreschi, Manel Jendoubi, Fanny André, Aurélie Jonneaux, C. Scalbert, Guillaume Garçon, Myriam Malet‐Martino, Stéphane Balayssac, Stéphane Rocchi et al. · 2013 · Oncotarget
  57. Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells
    Renata de Freitas Saito, Luciana Nogueira de Sousa Andrade, Silvina Odete Bustos, Roger J. Chammas · 2022 · Frontiers in Immunology
  58. Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer’s disease
    Traxler, Larissa, Herdy, Joseph R., Stefanoni, Davide, Eichhorner, Sophie, Pelucchi, Silvia, Szücs, Attila, Santagostino, Alice, Kim, Yongsung, Agarwal, Ravi K., Schlachetzki, Johannes C.M. et al. · 2022 · Cell Metabolism
  59. Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
    Nicola Antonio di Meo, Francesco M. Lasorsa, Monica Rutigliano, Davide Loizzo, Matteo Ferro, Alessandro Stella, Cinzia Bizzoca, Leonardo Vincenti, Savio Domenico Pandolfo, Riccardo Autorino B et al. · 2022 · International Journal of Molecular Sciences
  60. The Pentose Phosphate Pathway as a Potential Target for Cancer Therapy
    Eunae Sandra Cho, Yong Hoon Cha, Hyun Sil Kim, Nam Hee Kim, Jong In Yook · 2017 · Biomolecules & Therapeutics
  61. Revisiting the hallmarks of cancer: The role of hyaluronan
    Ilaria Caon, Barbara Bartolini, Arianna Parnigoni, Elena Caravà, Paola Moretto, Manuela Viola, Evgenia G. Karousou, Davide Vigetti, Alberto G. Passi · 2019 · Seminars in Cancer Biology
  62. A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer
    Haojie Jin, Siying Wang, Esther A. Zaal, Cun Wang, Hai-Qiu Wu, Astrid R. Bosma, Fleur Jochems, Nikita Isima, Guang‐Zhi Jin, Cor Lieftink et al. · 2020 · eLife
  63. Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
    Hayato Nakagawa, Yuki Hayata, Satoshi Kawamura, Tomoharu Yamada, Naoto Fujiwara, Kazuhiko Koike · 2018 · Cancers
  64. Sexual Dimorphism in Colon Cancer
    Maria Abancens, Viviana Bustos, Harry Myles Harvey, Jean McBryan, Brian Joseph Harvey · 2020 · Frontiers in Oncology
  65. Genetic Disruption of Lactate/H+ Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
    Ibtissam Marchiq, Renaud LeFloch, Danièle Roux, Marie‐Pierre Simon, Jacques Pouysségur · 2014 · Cancer Research
  66. Warburg and Beyond: The Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer
    Shamir Cassim, Milica Vučetić, Maša Ždralević, Jacques Pouysségur · 2020 · Cancers
  67. Harnessing metabolic dependencies in pancreatic cancers
    Joel Encarnación-Rosado, Alec C. Kimmelman · 2021 · Nature Reviews Gastroenterology & Hepatology
  68. Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity
    John D. Martin, Dai Fukumura, Dan Gabriel Duda, Yves Boucher, Rakesh K. Jain · 2016 · Cold Spring Harbor Perspectives in Medicine
  69. Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities
    Lanning, Nathan J., Castle, Joshua P., Singh, Simar J., Leon, Andre N., Tovar, Elizabeth A., Sanghera, Amandeep, MacKeigan, Jeffrey P., Filipp, Fabian V., Graveel, Carrie R. · 2017 · Cancer &amp; Metabolism
  70. ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients
    Esther Baena, Zhen Shao, Douglas E. Linn, Kimberly Glass, Melanie J. Hamblen, Yuko Fujiwara, Jonghwan Kim, Minh Nguyen, Xin Zhang, Frank J. Godinho et al. · 2013 · Genes & Development
  71. Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance
    Evan Noch, Rohan R. Ramakrishna, Rajiv Magge · 2018 · World Neurosurgery
  72. Connections between metabolism and epigenetics in cancers
    Chitra Thakur, Fei Chen · 2019 · Seminars in Cancer Biology
  73. Regulation of energy balance by inflammation: Common theme in physiology and pathology
    Hui Wang, Jianping Ye · 2014 · Reviews in Endocrine and Metabolic Disorders
  74. Drug-induced amino acid deprivation as strategy for cancer therapy
    Marcus Kwong Lam Fung, Gcf Chan · 2017 · Journal of Hematology & Oncology
  75. Metabolic reprogramming of host cells upon bacterial infection: Why shift to a Warburg‐like metabolism?
    Pedro Escoll, Carmen Buchrieser · 2018 · FEBS Journal
  76. CPT1A/2-Mediated FAO Enhancement—A Metabolic Target in Radioresistant Breast Cancer
    Shujun Han, Ryan Wei, Xiaodi Zhang, Nian Jiang, Ming Fan, Jie Huang, Bowen Xie, Lu Zhang, Weili Miao, Ashley Chen-Ping Butler et al. · 2019 · Frontiers in Oncology
  77. Melatonin and sirtuins: A “not-so unexpected” relationship
    Mayo, Juan C., Sainz, Rosa M., González Menéndez, Pedro, Cepas, Vanesa, Tan, Dun‐Xian, Reiter, Russel J. · 2017 · Journal of Pineal Research
  78. Targeting Glutamine Metabolism and Redox State for Leukemia Therapy
    Mark A. Gregory, Travis G. Nemkov, Hae J. Park, Vadym Zaberezhnyy, Sarah A. Gehrke, Biniam Adane, Craig T. Jordan, Kirk Charles Hansen, Angelo D’Alessandro, James V. DeGregori · 2019 · Clinical Cancer Research
  79. Microbial carcinogenesis: Lactic acid bacteria in gastric cancer
    Karla Vinasco, Hazel M. Mitchell, Nadeem Omar Kaakoush, Natalia Castaño‐Rodríguez · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  80. Non-coding RNAs: the new central dogma of cancer biology
    Phei Er Saw, Xiaoding Xu, Jianing Chen, Erwei Song · 2020 · Science China Life Sciences
  81. LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response
    Li, Fuming, Han, Xiangkun, Li, Fei, Wang, Rui, Wang, Hui, Gao, Yijun, Wang, Xujun, Fang, Zhaoyuan, Zhang, Wenjing, Yao, Shun et al. · 2015 · Cancer Cell
  82. Metabolic rewiring in melanoma
    Boris I. Ratnikov, David A. Scott, Andrei L. Osterman, Jeffrey W. Smith, Ze’ev A. Ronai · 2016 · Oncogene
  83. PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth
    Mami Morita, Taku Sato, Miyuki Nomura, Yoshimi Sakamoto, Yui Inoue, Ryota Tanaka, Shigemi Ito, Koreyuki Kurosawa, Kazunori Yamaguchi, Yuki Sugiura et al. · 2018 · Cancer Cell
  84. Oral squamous cell carcinoma diagnosed from saliva metabolic profiling
    Xiaowei Song, Xihu Yang, Rahul Narayanan, Vishnu Shankar, Sathiyaraj Ethiraj, Xiang Wang, Ning Duan, Yanhong Ni, Qingang Hu, Richard N. Zare · 2020 · Proceedings of the National Academy of Sciences
  85. Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells
    Du, Jiajun, Su, Yapeng, Qian, Chenxi, Yuan, Dan, Miao, Kun, Lee, Dongkwan, Ng, Alphonsus H. C., Wijker, Reto S., Ribas, Antoni, Levine, Raphael D. et al. · 2020 · Nature Communications
  86. Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal
    Jekaterina A. Erenpreisa, Mark Steven Cragg · 2013 · Cancer Cell International
  87. Cancer Metabolism and Drug Resistance
    Mahbuba Rahman, Mohammad R. Hasan · 2015 · Metabolites
  88. NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer
    Zuolei Jing, Qianmei Liu, Xinyuan He, Zhirong Jia, Zhizhong Xu, Bolin Yang, Ping Liu · 2022 · Journal of Experimental & Clinical Cancer Research
  89. HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
    Lee, Shen-Han, Golinska, Monika, Griffiths, John R. · 2021 · Cells
  90. Arginine starvation kills tumor cells through aspartate exhaustion and mitochondrial dysfunction
    Chun-Ting Cheng, Yue Qi, Yi-Chang Wang, Kevin K. Chi, Yiyin Chung, Ching Ouyang, Yun-Ru Chen, Myung Eun Oh, Xiangpeng Sheng, Yulong Tang et al. · 2018 · Communications Biology
  91. Histone acetyltransferase 1 is a succinyltransferase for histones and non-histones and promotes tumorigenesis
    Guang Yang, Ying Yuan, Hongfeng Yuan, Jiapei Wang, Haolin Yun, Yu Geng, Man Zhao, Linhan Li, Yejing Weng, Zixian Liu et al. · 2020 · EMBO Reports
  92. Glutaminolysis Promotes Collagen Translation and Stability via α-Ketoglutarate–mediated mTOR Activation and Proline Hydroxylation
    Ge, Jing, Cui, Huachun, Xie, Na, Banerjee, Sami, Guo, Sijia, Dubey, Shubham, Barnes, Stephen, Liu, Gang · 2018 · American Journal of Respiratory Cell and Molecular Biology
  93. Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors
    Nawal Bendris, Bénédicte Lemmers, Jean Marie Blanchard · 2015 · Cell Cycle
  94. Rapid Analysis of Glycolytic and Oxidative Substrate Flux of Cancer Cells in a Microplate
    Lisa Winer, Min Wu · 2014 · PLoS ONE
  95. One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy
    Shuvalov, Oleg, Petukhov, Alexey, Daks, Alexandra, Fedorova, Olga, Vasileva, Elena, Barlev, Nickolai A. · 2017 · Oncotarget
  96. Tp53-induced Glycolysis and Apoptosis Regulator (TIGAR) Protects Glioma Cells from Starvation-induced Cell Death by Up-regulating Respiration and Improving Cellular Redox Homeostasis
    Christina Wanka, Jörg Steinbach, Johannes Rieger · 2012 · Journal of Biological Chemistry
  97. Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype
    Min Liu, Fengling Luo, Chuanlin Ding, Sabrin Albeituni, Xiaoling Hu, Yunfeng Ma, Yihua Cai, Lacey R. McNally, Mary Ann Sanders, Dharamvir Jain et al. · 2015 · The Journal of Immunology
  98. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy
    Saleha Anwar, Anas Shamsi, Taj Mohammad, Asimul Islam, Md. Imtaiyaz Hassan · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  99. Dichloroacetate improves immune dysfunction caused by tumor‐secreted lactic acid and increases antitumor immunoreactivity
    Toshimitsu Ohashi, Takashi Akazawa, Mitsuhiro Aoki, Bunya Kuze, Keisuke Mizuta, Yatsuji Ito, Norimitsu Inoue · 2013 · International Journal of Cancer
  100. Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma
    Ruihua Ma, Wanguang Zhang, Ke Tang, Huafeng Zhang, Yi Zhang, Dapeng Li, Yong Li, Pingwei Xu, Shunqun Luo, Wenqian Cai et al. · 2013 · Nature Communications